FDA pauses Swedish diabetes company's phase III trial plans
![Photo: Diamyd Medical / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13188185.ece/ALTERNATES/schema-16_9/doc7h0ukx32t3s1l4ogbtl.jpg)
The US Food and Drug Administration (FDA) has put Diamyd Medical's planned phase III trial under a 'partial clinical hold'.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Novo Nordisk starts crucial trial of obesity tablet
For subscribers